XML 29 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
9 Months Ended108 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Net loss$ (5,469,502)$ (4,098,423)$ (29,514,506)
Adjustments to reconcile net loss to cash used in operating activities:   
Depreciation and amortization439,587435,9172,270,784
Stock-based compensation655,656331,1862,603,069
Intrinsic value of beneficial conversion feature associated with convertible debt257,973213,792471,765
Issuance of stock for technology and services  89,520
Impairment of intangible assets 19,67119,671
Loss on disposal of fixed assets6,009 36,477
Loss on derivative warrants66,820 66,820
Changes in:   
Prepaid expenses and other current assets(224,548)20,614(287,462)
Accounts payable and accrued liabilities(331,357)(419,634)61,524
Accrued interest158,672222,748463,721
Deferred rent6,0834,765121,394
Cash used in operating activities(4,434,607)(3,269,364)(23,597,223)
CASH FLOWS FROM INVESTING ACTIVITIES:   
Cash acquired in a business combination905,649 905,649
Purchases of fixed assets(112,195) (5,480,376)
Proceeds from sale of fixed assets  7,000
Purchases of short-term certificates of deposit  (5,500,730)
Proceeds from short-term certificates of deposit  5,500,730
Change in restricted cash500,000 (55,000)
Payment for intangible assets  (19,671)
Cash provided by (used) in investing activities1,293,454 (4,642,398)
CASH FLOWS FROM FINANCING ACTIVITIES:   
Proceeds from issuance of convertible notes 2,720,9852,720,985
Proceeds from long-term obligations  1,677,945
Payments on long-term obligations(675,743)(141,794)(1,227,944)
Payments on capital lease obligations(1,549)(1,446)(4,112)
Proceeds from issuance of common stock, net of issuance costs4,866,406 26,576,114
Proceeds from exercise of warrant  250,000
Repurchase of common stock  (31,667)
Cash in lieu of fractional shares in a business combination(145) (145)
Change in deferred issuance costs(130,800)99,461(130,800)
Cash provided by financing activities4,058,1692,677,20629,830,376
INCREASE (DECREASE) IN CASH AND EQUIVALENTS917,016(592,158)1,590,755
CASH AND EQUIVALENTS AT BEGINNING OF PERIOD673,739980,125 
CASH AND EQUIVALENTS AT END OF PERIOD1,590,755387,9671,590,755
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION   
Interest paid13,71642,888208,689
Fair value of derivative warrants reclassified to additional paid-in capital upon cashless exercise48,339 48,339
Issuance of common stock in connection with the conversion of notes payable and accrued interest3,184,707 3,184,707
Fair value of assets acquired in exchange for securities in a business combination78,407 78,407
Fair value of liabilities assumed in exchange for securities in a business combination(439,615) (439,615)
Excess of purchase price over net assets acquired in a business combination$ 1,675,462 $ 1,675,462